Dosage typically begins at 0.25 mg once weekly, with gradual increases to 0.5 mg, 1 mg, or up to 2.4 mg per week, depending on the specific brand and treatment goals
Discussing Retatrutide near you ensures that you are informed and prepared when it becomes available
The SURMOUNT-1 phase 3 double-blind, randomized, controlled trial in adults with obesity without diabetes received once weekly tirzepatide (5, 10, or 15 mg) versus placebo for 72 weeks [9]
There are no special cases
Starting the MindBody System 23 weeks before beginning your taper may help ease the transition by kickstarting natural GLP-1 Activation and microbiome changes.* However you transition, remember this is a journey, not a quick fix
And while not quite as effective as injectables, it is more accessible for some